The Evaluation of Thrombogenicity in Patients Undergoing WATCHMAN Left Atrial Appendage Closure Trial
Sponsor: Boston Scientific Corporation
Listed as NCT03040622, this observational or N/A phase trial focuses on Left Atrial Appendage Closure and WATCHMAN Device Implantation and remains completed. Sponsored by Boston Scientific Corporation, it has been updated 12 times since 2017, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Apr 2024 — Jul 2024 [monthly]
Completed
Status: Unknown Status → Completed
-
Nov 2021 — Apr 2024 [monthly]
Unknown Status
Status: Active Not Recruiting → Unknown Status
-
Jan 2021 — Nov 2021 [monthly]
Active Not Recruiting
▶ Show 7 earlier versions
-
Feb 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Nov 2019 — Feb 2020 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Sep 2018 — Nov 2019 [monthly]
Recruiting
-
Jun 2018 — Sep 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Feb 2017 — Aug 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Boston Scientific Corporation
- Inova Health Care Services
For direct contact, visit the study record on ClinicalTrials.gov .